Vaccine trial is ‘very promising’ for cancer patients

Vaccine trial is 'very promising' for cancer patients

(KELO) — A vaccine trial is showing promising results in treating skin cancer. Doctors at Sanford Health are researching and testing a new vaccine from Merck and Moderna that could prevent the recurrence of melanoma, a type of skin cancer.

Source: KELOLAND

Indexed: Fri, 21 Aug 2026 12:24:57 UTC

Not a government entity. Not a broker or agent. Public information index only. Verify independently.

Leave a Reply

Your email address will not be published. Required fields are marked *